Regeneron - Invidious

Regeneron

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.

View channel on YouTube

Switch Invidious Instance

Shorts

newest

oldest

popular

1:00

Did you answer correctly?

Regeneron

Shared 56 years ago

184 views

1:00

Investing in People: Regeneron’s Workforce and Community Goals

Regeneron

Shared 56 years ago

87 views

1:00

Evolving Bispecific Antibody Technology | Tech Trailblazers, Ep. 4

Regeneron

Shared 56 years ago

164 views

1:00

Environmental Sustainability in Regeneron’s 2030 Goals

Regeneron

Shared 56 years ago

93 views

1:00

Forget TikTok. Most people hear about trials here.

Regeneron

Shared 56 years ago

134 views

1:00

Can you guess what this is?

Regeneron

Shared 56 years ago

120 views

1:00

Regeneron ISEF 2026: A Global Experience

Regeneron

Shared 56 years ago

201K views

1:00

Supporting Access to Medicines: Regeneron’s 2030 Goals

Regeneron

Shared 56 years ago

203 views

1:00

Science is at the Core of Regeneron’s Responsibility Strategy

Regeneron

Shared 56 years ago

97 views

1:00

Radical Innovation: Break the Genetic Bottleneck with VelociGene®

Regeneron

Shared 56 years ago

176 views

1:00

Regeneron International Science and Engineering Fair 2026: More Than a Science Fair

Regeneron

Shared 56 years ago

161K views

1:00

Finding Data Worth Trusting with Christina Beechert | Tech Trailblazers, Ep. 3

Regeneron

Shared 56 years ago

405 views

1:00

3 facts you should know about clinical trials

Regeneron

Shared 56 years ago

128 views

1:00

What do you see?

Regeneron

Shared 56 years ago

72 views

1:00

10 Years of Regeneron STS Impact

Regeneron

Shared 56 years ago

212 views

1:00

Why do people join clinical trials? Here’s the top reason

Regeneron

Shared 56 years ago

126 views

1:00

What do you think this is?

Regeneron

Shared 56 years ago

145 views

1:00

Radical Innovation: Breaking the genetic engineering bottleneck

Regeneron

Shared 56 years ago

143 views

1:00

Regeneron STS 2026 Recap

Regeneron

Shared 56 years ago

328 views

1:00

Be Extraordinary: Meet Matteo Paz | 2025 STS Winner

Regeneron

Shared 56 years ago

363 views

1:00

Regeneron Science Talent Search: $150M Investment in Future Scientific Leaders

Regeneron

Shared 56 years ago

426K views

1:00

Be Extraordinary: Fueled by Legends | The Regeneron Science Talent Search's Impact

Regeneron

Shared 56 years ago

46K views

1:00

Patients trust this source the most. It’s not social media.

Regeneron

Shared 56 years ago

157 views

1:00

Be Extraordinary: Fueled by Legends | How Regeneron Science Talent Search Shapes Scientific Impact

Regeneron

Shared 56 years ago

130K views

1:00

Radical Innovation: Creating Simple Solutions for Patients

Regeneron

Shared 56 years ago

109 views

1:00

Be Extraordinary: Fueled by Legends | How the Regeneron Science Talent Search Fuels Confidence

Regeneron

Shared 56 years ago

213K views

1:00

Be Extraordinary: Fueled by Legends I The Regeneron Science Talent Search Experience

Regeneron

Shared 56 years ago

270K views

1:00

Radical Innovation: How Veloci-Bi® Powers Scientific Breakthroughs

Regeneron

Shared 56 years ago

114K views

1:00

Clinical Trials Day 2025: Powered By Purpose

Regeneron

Shared 56 years ago

99 views

1:00

Clinical Trials Day 2025: You Make It Possible

Regeneron

Shared 56 years ago

177 views

1:00

Clinical Trials Day 2025: Thank You

Regeneron

Shared 56 years ago

53 views

1:00

Do you think you know who qualifies for a trial? Think again.

Regeneron

Shared 56 years ago

62 views

1:00

What do you think you’re looking at?

Regeneron

Shared 56 years ago

292 views

1:00

Introducing STEM-Fueled

Regeneron

Shared 56 years ago

458 views

1:00

Celebrating Regeneron Day for Doing Good 2025

Regeneron

Shared 56 years ago

368 views

1:00

Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou

Regeneron

Shared 56 years ago

202 views

1:00

Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou

Regeneron

Shared 56 years ago

107 views

1:00

Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou

Regeneron

Shared 56 years ago

129 views

1:00

How Regeneron Scientists Study Disease Up Close

Regeneron

Shared 56 years ago

86 views

1:00

Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik

Regeneron

Shared 56 years ago

316 views

1:00

Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik

Regeneron

Shared 56 years ago

231 views

1:00

Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik

Regeneron

Shared 56 years ago

290 views

1:00

Can you guess what this is?

Regeneron

Shared 56 years ago

166 views

1:00

Can you tell what you're looking at? 👀

Regeneron

Shared 56 years ago

160 views

1:00

Can you tell what you're looking at? 👀 — Part 2

Regeneron

Shared 56 years ago

159 views

1:00

Can you tell what you're looking at? 👀

Regeneron

Shared 56 years ago

186 views

1:00

Opening Up Misconceptions of EoE

Regeneron

Shared 56 years ago

109K views